agilon health (AGL) Stock Forecast & Price Target

$1.70 +0.12 (+7.23%)

(As of 12:05 PM ET)

agilon health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce

Based on 20 Analyst Ratings

Sell
3

Hold
15

Buy
2

Based on 20 Wall Street analysts who have issued ratings for agilon health in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 20 analysts, 3 have given a sell rating, 15 have given a hold rating, and 2 have given a buy rating for AGL.

Consensus Price Target

$6.05
254.84% Upside

According to the 20 analysts' twelve-month price targets for agilon health, the average price target is $6.05. The highest price target for AGL is $18.00, while the lowest price target for AGL is $1.75. The average price target represents a forecasted upside of 254.84% from the current price of $1.71.

AGL Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	8 Buy rating(s)
Hold	15 Hold rating(s)	14 Hold rating(s)	14 Hold rating(s)	1 Hold rating(s)
Sell	3 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$6.05	$8.03	$8.57	$22.50
Forecasted Upside	254.84% Upside	186.83% Upside	90.79% Upside	104.73% Upside
Consensus Rating	Reduce	Hold	Hold	Moderate Buy

Discover 2025’s Top Stock Pick 📈 (Ad)

As a seasoned trader, you understand the importance of identifying high-potential opportunities before they become mainstream. We’ve conducted in-depth analysis to pinpoint the #1 stock opportunity set to dominate in 2025 and beyond. Our exclusive report provides the strategic insights and advanced metrics that experienced investors like you need to stay ahead of the market.

[Get My Free Report]

AGL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AGL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

agilon health Stock vs. The Competition

Type	agilon health	Medical Companies	S&P 500
Consensus Rating Score	1.95	2.80	2.50
Consensus Rating	Reduce	Moderate Buy	Moderate Buy
Predicted Upside	280.50% Upside	27,981.08% Upside	9.99% Upside
News Sentiment Rating	Neutral News See Recent AGL News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/19/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$3.00 ➝ $3.00	+86.92%
11/13/2024	Citigroup 3 of 5 stars	D. Grosslight Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sell ➝ Sell	$2.50 ➝ $1.75	-5.41%
11/12/2024	Stifel Nicolaus 4 of 5 stars		Lower Target	Hold ➝ Hold	$7.00 ➝ $2.00	+6.95%
11/11/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$6.00 ➝ $2.00	-1.96%
11/11/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$5.00 ➝ $2.00	+7.53%
11/11/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Davides Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
This thing would have won 534 of the 550 trades placed in the last 11 years (Ad) Choosing what your next move will be is one of the most difficult choices investors are faced with today — especially in turbulent markets like these. But what if there was one technique that checked all these boxes? ✅ Allows traders of all stripes to target extra income week after week ✅ Won 534 of 550 trades according to our backtesting on 11-years worth of data ✅ Has maintained a shocking 97.1% through every market condition imaginable ✅ Sets up “Weekly Windfalls” every week so that it’s never trading opposite the broad market direction Well, we’re here to tell you, that strategy isn’t a pipe dream… It’s the same flagship strategy Chris Pulver just released an urgent briefing on! And your friends at Prosperity Pub have secured the video just for you. And with the very next trade dropping THIS WEEK you couldn't have better timing! While we cannot promise future returns or against losses, you have to… While we cannot promise future returns or against losses, you have to… Check out this training ses
11/8/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Daniels Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
10/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	In-Line ➝ In-Line	$7.00 ➝ $4.00	+25.79%
10/2/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Underperform	$3.00	-14.53%
8/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$5.00 ➝ $4.00	-27.67%
8/8/2024	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $9.00	+57.89%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$6.00	+4.08%
5/24/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$6.40 ➝ $6.50	+15.15%
2/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold	$25.00 ➝ $6.50	+3.67%
1/8/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
1/8/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
1/8/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
1/5/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Neutral	$17.00 ➝ $9.00	+12.36%
12/11/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$14.00	+21.21%
11/13/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$23.00 ➝ $16.00	+47.47%
3/6/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$21.00 ➝ $30.00	+18.95%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:30 PM ET.

AGL Forecast - Frequently Asked Questions

: According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for agilon health is $6.05, with a high forecast of $18.00 and a low forecast of $1.75.
: 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 3 sell ratings, 15 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" AGL shares.
: According to analysts, agilon health's stock has a predicted upside of 254.84% based on their 12-month stock forecasts.
: Over the previous 90 days, agilon health's stock had 3 downgrades by analysts.
: agilon health has been rated by research analysts at Bank of America, Barclays, Citigroup, Evercore ISI, JMP Securities, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, and William Blair in the past 90 days.
: Analysts like agilon health less than other "medical" companies. The consensus rating for agilon health is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AGL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Discover 2025’s Top Stock Pick 📈 (Ad)

[Get My Free Report]

This page (NYSE:AGL) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

agilon health (AGL) Stock Forecast & Price Target